Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with IOVA: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
IOVA
Iovance Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
IOVA
Iovance Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IOVA: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
IOVA, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only IOVA
12
NVS
Novartis Pharma
supplier
—
Boehringer Ingelheim Biopharmaceuticals GmbH
unlisted
supplier
—
National Cancer Institute (NCI)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
National Institutes of Health (NIH)
unlisted
supplier
8 more · IOVA chain
›
AMGN
Amgen Inc
Change
460.67
· pre 462.76
· delayed
Mkt cap
$249.4B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
IOVA
Iovance Biotherapeutics, Inc.
Change
8.85
· pre 9.00
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$4.0B
Revenue
$99M
Q2 FY26
Revenue
$264M
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
AMGN
Amgen Inc
vs
IOVA
Iovance Biotherapeutics, Inc.
460.67
pre 462.76
delayed
Price
8.85
pre 9.00
delayed
$249.4B
Mkt cap
$4.0B
Q2 FY26
$10.1B
Revenue
$99M
Q2 FY26
FY25
$36.8B
Revenue
$264M
FY25
Change
Change
AMGN
460.67
vs
IOVA
8.85
Pre-market
Nov 4 '26
delayed